Implantable Collamer Lens (ICL) Market to Reach USD 810 Million by 2031 | CAGR 13.5% | North America Leads with 38% Share | Key Players: STAAR Surgical Company, Zeiss Meditec

Market Overview

The Global Implantable Collamer Lens (ICL) Market reached US$ 334 million in 2023 and is projected to grow to US$ 810 million by 2031, registering a CAGR of 13.5% during the forecast period 2024-2031. Implantable Collamer Lenses are intraocular lenses designed for surgical implantation to correct refractive errors, particularly high myopia, in patients who are unsuitable for traditional glasses, contact lenses, or laser-based vision correction procedures. Unlike conventional contact lenses that rest on the corneal surface, ICLs are placed inside the eye, working in conjunction with the eye's natural lens to provide durable and high-quality vision correction.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/implantable-collamer-lens-market?Juli

ICLs are particularly advantageous for patients with severe myopia or other refractive errors that cannot be effectively corrected through laser surgery (LASIK or PRK). They help maintain depth perception, contrast sensitivity, and low-light vision, which are critical for activities such as nighttime driving or sports. Additionally, as a reversible and biocompatible solution, ICLs offer a safe and effective alternative for patients seeking improved visual acuity without permanently altering the corneal structure.

Recent Developments:

✅ January 2026: A leading ophthalmic device manufacturer launched a next-generation ICL with enhanced UV protection and improved biocompatibility for patients with high myopia, targeting markets in North America and Europe.

✅ November 2025: A global eye-care company introduced a preloaded ICL delivery system that simplifies the surgical procedure, reducing operation time and improving patient outcomes in clinical settings.

✅ August 2025: A regional medical device firm partnered with leading eye hospitals to expand access to ICL implantation surgeries, focusing on advanced training programs for surgeons in Asia-Pacific.

✅ June 2025: A U.S.-based ICL manufacturer announced FDA approval for an extended range of lens powers, enabling correction for higher degrees of myopia previously not treatable with standard ICLs.

✅ March 2025: An Asian ophthalmic company launched a customized ICL solution integrating personalized sizing and curvature options, enhancing post-operative visual acuity and comfort for patients.

✅ January 2023: A European eye-care technology company introduced foldable Collamer lenses that allow minimally invasive implantation, improving recovery times and reducing complication risks for high-myopia patients.

Buy Now & Unlock 360° Market Intelligence:-https://www.datamintelligence.com/buy-now-page?report=implantable-collamer-lens-market?Juli

Key Players:

STAAR Surgical Company - Holds 25% share, driven by its pioneering Visian ICL portfolio and global distribution network.

Zeiss Meditec - Holds 18% share, supported by advanced optical technology and integration with diagnostic systems.

Rayner Intraocular Lenses Limited - Holds 12% share, leveraging precision lens design and strong presence in European markets.

Care Group - Holds 10% share, focused on innovative lens materials and surgeon training programs.

Price Vision Group - Holds 8% share, with a growing footprint in the North American ICL segment.

Lense Home - Holds 7% share, emphasizing affordable lens options for emerging markets.

Beye, LLC - Holds 5% share, providing niche customized ICL solutions.

Market Segmentation:

By Type: The posterior chamber phakic lenses dominate the market with a 65% share, owing to their widespread adoption in correcting high myopia and minimal impact on corneal anatomy. Anterior chamber phakic lenses account for 35%, primarily used in niche cases where posterior chamber implantation is not feasible or contraindicated.

By Application: High myopia remains the largest application segment, holding 55% of the market, as ICLs are especially effective for patients with severe nearsightedness that cannot be treated with conventional lenses or laser surgery. Refractive surgery enhancements constitute 20%, serving patients seeking post-LASIK or post-PRK adjustments. Myopic astigmatism accounts for 15%, while other applications, including hyperopia correction and complex refractive errors, make up the remaining 10%.

By End-User: Ophthalmic clinics represent 50% of the market share, driven by specialized refractive surgery services and the increasing number of trained ophthalmic surgeons. Hospitals account for 35%, providing ICL procedures as part of comprehensive eye care and surgical services. Ambulatory surgical centers (ASCs) contribute 15%, benefiting from growing outpatient procedures and minimally invasive refractive surgeries.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/implantable-collamer-lens-market?Juli

Regional Insights:

North America holds the largest market share at 38%, driven by high prevalence of myopia, advanced ophthalmic infrastructure, and early adoption of ICL technologies. The U.S. and Canada benefit from favorable reimbursement policies, widespread awareness about refractive surgery, and increasing demand for premium vision correction procedures.

Europe accounts for 28% of the market, led by countries like Germany, France, and the U.K., where strong healthcare systems, growing ophthalmic clinics, and rising disposable incomes support the adoption of ICLs. Investments in research and collaborations between hospitals and lens manufacturers also drive growth.

Asia-Pacific represents 25% of the market, with countries such as China, India, Japan, and South Korea witnessing a surge in high myopia cases, expanding ophthalmic facilities, and increasing awareness of advanced vision correction options. Government health initiatives and the growing middle-class population are further accelerating market growth.

Market Dynamics:

Drivers:
The growing prevalence of refractive errors, including myopia, hyperopia, and astigmatism, is a major driver for the ICL market. As more individuals seek long-term, reliable vision correction solutions, demand for implantable collamer lenses is increasing. ICLs provide a permanent alternative for those who are not ideal candidates for laser eye surgery or who prefer to reduce dependence on glasses and contact lenses. Hyperopia, which becomes more common with age, particularly boosts the appeal of ICLs, offering lasting correction. According to the American Academy of Ophthalmology (2023), hyperopia affects approximately 10% of the U.S. population, or around 14 million people. In infants, mild hyperopia is common, and moderate to high hyperopia significantly increases the risk of developing strabismus if left uncorrected, with prevalence rates of 13% at age 6 and 5% at age 12 in Australia. The increasing prevalence of such refractive conditions across age groups, combined with rising awareness of advanced vision correction methods, continues to accelerate market growth globally.

Restraints
The high cost of ICL procedures remains a key restraint on market expansion. The total cost includes the price of the lens, surgical fees, and associated pre- and post-operative care, which can range from $3,500 to $5,000 per eye depending on the lens type, surgeon expertise, and geographic location. Such costs make ICLs less accessible to a broader population, particularly in emerging markets or among individuals with limited financial resources. The expense compared to alternative vision correction options, such as conventional contact lenses or laser surgery, limits widespread adoption, slowing potential market growth despite rising demand for effective and permanent vision correction solutions.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.